Impact of Best Practice Advisory on Reducing Contraindicated Medications and Improving Medication Management in Hospitalized Patients with Parkinson’s Disease (P7-5.019)
To evaluate the impact of an electronic medical record (EMR) warning, also known as Best Practice Advisory (BPA), designed to reduce the administration of contraindicated dopamine-blocking agents and improve the adherence to home medication regimens for hospitalized patients with Parkinson’s disease (PD).
Authors
- Annie Jiang (ORCID: https://orcid.org/0000-0002-6540-1409)
- Ariel Sacknovitz (ORCID: https://orcid.org/0009-0008-6236-1190)
- Katherine Amodeo (ORCID: https://orcid.org/0000-0002-8968-1011)
- Carolin Dohle
- Zhimin Xu (ORCID: https://orcid.org/0000-0002-4633-8969)
- Colleen Bond (ORCID: https://orcid.org/0009-0009-5440-5891)
- Sai Nishitha Bujala
Institutions
- Westchester Medical Center (US)
- New York Medical College (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208644
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00